Related Experiment Video
Updated: Jul 16, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Bullous Hemorrhagic Dermatosis Induced by Enoxaparin: About a Case in Madagascar
Fenohasina Rakotonandrasana1, Fandresena Arilala Sendrasoa1, Andrianandrianina Mbolatiana Kiady Armando Rakotomanana1
1Department of Dermatology, Faculty of Medicine, University of Antananarivo, Antananarivo 101, Madagascar.
Abstract:
Bullous hemorrhagic dermatosis is an adverse reaction occurring within 5 to 21 days after anticoagulation; the diagnosis is to be evoked in the presence of hemorrhagic bullous lesions at a distance from the injection site in the days following the introduction of anticoagulant; this is a diagnosis of exclusion. It is a rare pathology that mainly affects the elderly. A 54-year-old man presented with bullous hemorrhagic lesions on the left upper limb starting at the 4th day after enoxaparin injection, diagnosed as a bullous hemorrhagic dermatosis induced by enoxaparin. We report the first case of bullous hemorrhagic dermatosis induced by enoxaparin in Madagascar.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Endocarditis II: Clinical Features of Infective Endocarditis
Rocky Mountain Spotted Fever
Smallpox

